Expert Interview
A Second look: Discussing the recent label expansion of TEPEZZA (teprotumumab-trbw) for patients with TED, regardless of disease activity or duration.
Ticker(s): AMGNInstitution: West Texas Eye Associates
- Ophthalmologist, fellowship-trained Corneal and External Disease specialist.
- Manages TED patients and prescripes Tepezza to 8 TED patients
- Clinical and research interests in cornea, external disease, cataract, and refractive surgery
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
